Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.
Ravi P, Zhong C, Xie W, Kelly E, Whelpley B, Kuczmarski K, Beltran H, Kilbridge KL, King MT, McGregor BA, Morgans AK, Pomerantz M, Taplin ME, Tewari AK, Viswanathan SR, Wei XX, Anh Huynh M, Choudhury AD.
Ravi P, et al. Among authors: kelly e.
Eur Urol Oncol. 2024 Nov 14:S2588-9311(24)00243-8. doi: 10.1016/j.euo.2024.10.014. Online ahead of print.
Eur Urol Oncol. 2024.
PMID: 39547900